EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Red Blood Cell Exchange in Sickle Cell Disease Care: A Comprehensive Review

Mahtab Mashayekhi, Mojtaba Akhtari, Akshat Jain, Nasim Salimiaghdam iD, Amir Abdipour

Therapeutic Apheresis and Dialysis · 2026-08 · 30 (4) · 482-488

DOI: 10.1002/1744-9987.70155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 11.05.2026. Verfasst von Mahtab Mashayekhi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology, Loma Linda University Medical Center, Loma Linda, California, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Erythrocyte Transfusion. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erythrocytaphoresis or RBC exchange (RBCX) is a key intervention in the management of sickle cell anemia for both chronic prophylaxis and emergent clinical care during sickle cell disease (SCD) emergencies. RBCX removes sickled RBCs while replacing them with donor RBCs and reducing hemoglobin S (HbS) levels. Unlike simple transfusion, it minimizes iron overload and avoids fluid overload, making it a mainstay for the management of acute stroke, acute chest syndrome, and other settings where fluid overload can complicate disease morbidity. Chronic RBCX has shown benefit in not only improving oxygenation and reducing hospitalization rates but also improving overall quality of life in SCD patients. Advances in apheresis technology and personalized transfusion have brought new opportunities for enhancement in safety, efficacy, and feasibility of this therapeutic modality. In this review, we explore the clinical efficacy and role of chronic RBC exchange and its long‐term outcomes in managing complications of SCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellErythrocyte TransfusionHumansQuality of LifeHemoglobin, SickleIron OverloadErythrocytes

Substanzen

Hemoglobin, Sickle

Autor:innen und Institutionen

  • Department of Medicine, Division of Nephrology, Loma Linda University Medical Center, Loma Linda, California, USA.
  • Department of Medicine, Division of Transplant, Cellular Therapy and Hematological Malignancies, Loma Linda University School of Medicine, Loma Linda, California, USA.
  • Department of Pediatrics, Division of Hematology/Oncology, Loma Linda University School of Medicine, Loma Linda, California, USA.
  • Department of Medicine, Capital Health Regional Medical Center, Trenton, New Jersey, USA.

ORCID-Profile: Nasim Salimiaghdam

Zitieren

APA

Mashayekhi, M., Akhtari, M., Jain, A., Salimiaghdam, N., & Abdipour, A. (2026). Red Blood Cell Exchange in Sickle Cell Disease Care: A Comprehensive Review. Therapeutic Apheresis and Dialysis, 30(4), 482-488. https://doi.org/10.1002/1744-9987.70155

Vancouver

Mashayekhi M, Akhtari M, Jain A, Salimiaghdam N, Abdipour A. Red Blood Cell Exchange in Sickle Cell Disease Care: A Comprehensive Review. Therapeutic Apheresis and Dialysis. 2026;30(4):482-488. doi:10.1002/1744-9987.70155

BibTeX
@article{Mashayekhi2026,
  author = {Mashayekhi, Mahtab and Akhtari, Mojtaba and Jain, Akshat and Salimiaghdam, Nasim and Abdipour, Amir},
  title = {Red Blood Cell Exchange in Sickle Cell Disease Care: A Comprehensive Review},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  volume = {30},
  number = {4},
  pages = {482--488},
  doi = {10.1002/1744-9987.70155}
}
Kostenlos starten →